Chemical Compound

Mavorixafor

CAS Registry Number 558447-26-0
Mavorixafor chemical structure
Primary Record

Mavorixafor

In stock
5,252 g
Purity
99.4 %
CAS
558447-26-0

Compound Identifiers & Properties

CAS
558447-26-0
PubChem CID
11256587
SMILES
C1C[C@@H](C2=C(C1)C=CC=N2)N(CCCCN)CC3=NC4=CC=CC=C4N3
Canonical SMILES
NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21

Names & Synonyms

  • Mavorixafor
  • AMD-070
  • 558447-26-0
  • mavorixaforum
  • XOLREMDI
  • AMD070
  • Mavorixafor [USAN]
  • AMD 070
  • AMD11070
  • Xolremdi (TN)
  • 0G9LGB5O2W
  • Mavorixafor (USAN)
  • UNII-0G9LGB5O2W
  • (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
  • Cxcr4 inhibitor x4p-001
  • X4p001
  • AMD-11070
  • AMD-070 hydrochloride
  • AMD-070; Mavorixafor
  • RefChem:155995
  • MAVORIXAFOR [INN]
  • MFCD11977316
  • D0O2XQ
  • CHEMBL518924
  • A1D8L
  • X4P-001
  • MAVORIXAFOR [WHO-DD]
  • AMD 11070
  • GTPL8580
  • orb1296155
  • SCHEMBL2511950
  • C21H27N5
  • SCHEMBL29379072
  • SCHEMBL29701264
  • X 4P-001
  • CTK8C0587
  • DTXSID60971247
  • QCR-228
  • CHEBI:138865
  • GLXC-04447
  • X4P-001-IO
  • X4P-001-LD
  • BCP07108
  • compound 2 [PMID: 20297846]
  • EX-A2661
  • IXA44726
  • AMD-070 (AMD11070)
  • 8157AB
  • ANW-64931
  • BDBM50315305
  • NSC775637
  • RW3962
  • WHO 10724
  • ZINC33359232
  • AMD-070 HCl 75%(w/w%)
  • CS-0352
  • CS-1257
  • DB05501
  • NSC-775637
  • X4P 001
  • CID11256587
  • EBC-2562075
  • NCGC00378947-01
  • NCGC00378947-02
  • NCGC00378947-03
  • AJ-85915
  • DA-50384
  • HY-50101
  • SY260541
  • TC-153676
  • NS00071960
  • ST24036370
  • J2.798.825C
  • A11315
  • C20266
  • D11510
  • F31237
  • N'-(1H-benzimidazol-2-ylmethyl)-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
  • W-5505
  • A857602
  • S14-0353
  • BRD-K42948882-305-01-1
  • Q27074430
  • N-(1H-benzimidazol-2-ylmethyl)-N-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
  • N-(1H-benzoimidazol-2-ylmethyl)-N-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
  • N'-((1H-benzo(d)imidazol-2-yl)methyl)-N'-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
  • N1-(1H-BENZIMIDAZOL-2-YLMETHYL)-N1-((S)-5,6,7,8-TETRAHYDROQUINOLIN-8-YL)-BUTANE-1,4-DIAMINE
  • (S)-N1-[(2-Benzimidazolyl)methyl]-N1-(5,6,7,8-tetrahydro-8-quinolyl)-1,4-butanediamine
  • N-(1H-Benzimidazol-2-ylmethyl)-N-(8S)-5,6,7,8-tetrahydro-8-quinolinyl-1,4-butanediamine
  • (8S)-N-(4-aminobutyl)-N-((1H-1,3-benzodiazol-2-yl)methyl)-5,6,7,8-tetrahydroquinolin-8-amine
  • (8S)-N-(4-aminobutyl)-N-[(1H-1,3-benzodiazol-2-yl)methyl]-5,6,7,8-tetrahydroquinolin-8-amine
  • (S)-N-((1H-benzo[d]imidazol-2-yl)methyl)-N-(4-aminobutyl)-5,6,7,8-tetrahydroquinolin-8-amine
  • (S)-N1-((1H-Benzo(d)imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
  • 1,4-BUTANEDIAMINE, N-(1H-BENZIMIDAZOL-2-YLMETHYL)-N-((8S)-5,6,7,8-TETRAHYDRO-8-QUINOLINYL)-
  • 558441-90-0
  • 690656-53-2
  • AMD11070; AMD-11070; AMD 11070;AMD 070; AMD070; X4P-001; X4P 001; X4P001; mavorixafor
  • N'-(1H-Benzo[d]imidazol-2-ylmethyl)-N'-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine Trihydrobromide Dihydrate
  • N-(1H-benzimidazol-2-ylmethyl)-N-((8S)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
  • N-(1H-Benzoimidazole-2-ylmethyl)-N-(5,6,7,8-tetrahydroquinoline-8alpha-yl)-1,4-butanediamine
  • N~1~-[(1H-1,3-Benzimidazol-2-yl)methyl]-N~1~-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
  • N~1~-[(1H-Benzimidazol-2-yl)methyl]-N~1~-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine